UK Drug Safety Update · March 15, 2022

Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision

Healthcare professionals reminded of serious and potentially life-threatening side effects of amiodarone, particularly affecting lung, liver, and thyroid; patient supervision and review required.

Low obligation Product class Pharmaceuticals UK Pharmacovigilance

Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should be supervised and reviewe…

Read the official source ↗

Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.